resiquimod has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bie, N; Chen, X; Gan, L; Li, J; Li, S; Li, X; Liu, H; Wei, Z; Xu, H; Yan, Y; Yang, X; Yong, T; Zhang, B; Zhang, X | 1 |
1 other study(ies) available for resiquimod and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Cell microparticles loaded with tumor antigen and resiquimod reprogram tumor-associated macrophages and promote stem-like CD8
Topics: alpha-Fetoproteins; Animals; Antigens, Neoplasm; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Immunosuppressive Agents; Liver Neoplasms; Male; Mice; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |